Calidi Biotherapeutics, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
CLDI, CLDI-WT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
4475 Executive Drive, Suite 200, San Diego, California

There are no Buy or Sell transactions made by insiders since 7/8/2023

Calidi Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Allan Camaisa CEO and Chairman of the Board, Director, 10%+ Owner $16.1 M Jun 17, 2024
Polar Asset Management Partners Inc. 10%+ Owner $4.33 M Oct 19, 2022
Stephen Thesing Chief Business Officer $849 K Sep 12, 2023
Boris Radoslavov Minev Interim Chief Medical Officer $764 K Jun 17, 2024
Thomas Vecchiolla Director $657 K Dec 21, 2023
Antonio Fernandez SVP, Global Head of R&D $590 K Sep 12, 2023
Tony Kalajian Chief Acctg Officer, Int. CFO $502 K Sep 12, 2023
Heehyoung Lee Director, Former Director $444 K Oct 10, 2023
Wendy Pizarro Campbell Chief Admin. and Legal Officer $292 K Jun 17, 2024
Alfonso G. Zulueta Director $240 K Dec 21, 2023
James A. Schoeneck Director $214 K Jun 28, 2024
Scott Leftwich Director $112 K Jun 28, 2024
Amish Patel VP of Technical Operations $52.7 K Sep 12, 2023
George Ng Director $50.6 K Sep 12, 2023
David Sans Chief of Corporate Development $33 K Sep 12, 2023
Alan R. Stewart Director $30.8 K Jun 28, 2024
David LaPre Director Jan 1, 2024
Andrew Jackson Chief Financial Officer Jun 17, 2024
First Light Acquisition Group, LLC 10%+ Owner Jun 16, 2023
Michael J. Alber Chief Financial Officer Sep 9, 2021
Michael Ruettgers Director Sep 9, 2021
William Fallon Director Sep 9, 2021
Jeanne Tisinger Director Sep 9, 2021
William John Weber Chief Executive Officer, Director, 10%+ Owner Sep 9, 2021
Hudson Bay Capital Management LP 10%+ Owner Sep 12, 2023

Recent Insider Transactions by Companies or Individuals for Calidi Biotherapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership